Inventor · disambiguated record
Ronald D. Seidel, Iii
Also filed as: SEIDEL III RONALD D
36 granted patents·72 pending applications·328 citations·filing 2013–2025
98Inventor score
Files withCUE BIOPHARMA INC96ALBERT EINSTEIN COLLEGE MEDICINE6CROSSLINK THERAPEUTICS INC3ALBERT EINSTEIN COLLEGE MEDICINE INC2ALBERT EINSTEIN COLLEGE MEDICINE YESHIVA UNIV1
Top patents by PatentIndex Score
108 records- 0198US11905320B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Feb 20, 2024·5 cites·30 claims
- 0298US11851467B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Dec 26, 2023·9 cites·20 claims
- 0398US11767355B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2022·Granted Sep 26, 2023·13 cites·28 claims
- 0498US11739133B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Aug 29, 2023·12 cites·30 claims
- 0598US11708400B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Jul 25, 2023·15 cites·14 claims
- 0698US11530248B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Dec 20, 2022·14 cites·24 claims
- 0798US11505588B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Nov 22, 2022·15 cites·26 claims
- 0898US11479595B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2020·Granted Oct 25, 2022·19 cites·19 claims
- 0998US11401314B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Granted Aug 2, 2022·17 cites·16 claims
- 1098US11377478B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Jul 5, 2022·25 cites·18 claims
- 1198US11370821B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Granted Jun 28, 2022·20 cites·21 claims
- 1298US11117945B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Granted Sep 14, 2021·28 cites·30 claims
- 1398US11104712B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2021·Granted Aug 31, 2021·19 cites·14 claims
- 1498US10927161B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·33 cites·16 claims
- 1598US10927158B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Granted Feb 23, 2021·36 cites·16 claims
- 1697US12180258B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Dec 31, 2024·1 cites·30 claims
- 1797US12152061B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Nov 26, 2024·1 cites·20 claims
- 1897US12145973B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Nov 19, 2024·1 cites·20 claims
- 1997US11987610B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted May 21, 2024·1 cites·15 claims
- 2097US11702461B2T-cell modulatory multimeric polypeptides comprising reduced-affinity immunomodulatory polypeptidesCUE BIOPHARMA INC·Filed 2020·Granted Jul 18, 2023·9 cites·18 claims
- 2196US11878062B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Jan 23, 2024·9 cites·4 claims
- 2296US11505591B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2017·Granted Nov 22, 2022·14 cites·17 claims
- 2395US11692018B2TGF-β polypeptidesCUE BIOPHARMA INC·Filed 2022·Granted Jul 4, 2023·2 cites·23 claims
- 2494US12029782B2MHC class II T-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (T1D) and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Jul 9, 2024·1 cites·2 claims
- 2594US2025092110A1T-Cell Modulatory Multimeric Polypeptides and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2693US12006348B2T-cell modulatory multimeric polypeptide with conjugation sites and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Granted Jun 11, 2024·3 cites·8 claims
- 2793US2025145685A1Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 2892US11958893B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2021·Granted Apr 16, 2024·1 cites·16 claims
- 2991US2025136660A1Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3090US2024166719A1Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 3189US11993641B2Methods for modulating an immune responseCUE BIOPHARMA INC·Filed 2023·Granted May 28, 2024·0 cites·19 claims
- 3286US12257311B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Mar 25, 2025·0 cites·33 claims
- 3385US12485184B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Granted Dec 2, 2025·0 cites·1 claims
- 3484US2025002556A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3584US2025206794A1TGF-Beta PolypeptidesCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3682US12485183B2Multimeric T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2022·Granted Dec 2, 2025·0 cites·1 claims
- 3782US11339201B2Variant PD-L1 polypeptides, T-cell modulatory multimeric polypeptides, and methods of use thereofALBERT EINSTEIN COLLEGE MEDICINE·Filed 2017·Granted May 24, 2022·3 cites·18 claims
- 3882US2025092113A1Multimeric T-Cell Modulatory Polypeptides and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 3981US2022064247A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2021·Application pending·0 cites
- 4080US12421287B2T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2025·Granted Sep 23, 2025·0 cites·21 claims
- 4180US2024025964A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2023·Application pending·0 cites
- 4280US2024299515A1Mhc class ii t-cell modulatory multimeric polypeptides for treating type 1 diabetes mellitus (t1d) and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4378US2024368245A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4478US2024409606A1T-Cell Modulatory Multimeric Polypeptide with Conjugation Sites and Methods of Use ThereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4578US2025120996A1T-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4677US11226339B2Methods for high throughput receptor:ligand identificationALBERT EINSTEIN COLLEGE MEDICINE·Filed 2018·Granted Jan 18, 2022·1 cites·7 claims
- 4777US2025074960A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4876US2024376177A1Multimeric t-cell modulatory polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2024·Application pending·0 cites
- 4976US2020207824A1T-cell modulatory multimeric polypeptides and methods of use thereofCUE BIOPHARMA INC·Filed 2020·Application pending·0 cites
- 5075US12180297B2ATP-dependent agonists of immune cells function as anticancer agentsCROSSLINK THERAPEUTICS INC·Filed 2024·Granted Dec 31, 2024·0 cites·27 claims
Showing the top 50 of 108 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ronald D. Seidel, Iii files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →